HilleVax, Inc. (HLVX)
| Market Cap | 102.70M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -71.10M |
| Shares Out | 49.50M |
| EPS (ttm) | -1.43 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 209,903 |
| Open | 2.075 |
| Previous Close | 2.060 |
| Day's Range | 2.065 - 2.075 |
| 52-Week Range | 1.340 - 2.170 |
| Beta | 0.77 |
| Analysts | Hold |
| Price Target | 2.00 (-3.61%) |
| Earnings Date | Aug 6, 2025 |
About HLVX
HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and ... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for HLVX stock is "Hold" and the 12-month stock price target is $2.0.
News
HilleVax Reports Second Quarter 2025 Financial Results
BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial r...
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hille...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.
NEW YORK , Aug. 5, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the proposed acquisi...
Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more than 200 points on Monday.
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announ...
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates inadults as...
Frazier Life Sciences Appoints Aditya Kohli to Partner
PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner. ...
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adult...
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine can...
Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
Stakeholders Of HilleVax Inc Are Urged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
Stakeholders Of Hillevax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HilleVax, Inc. (“HilleVax” or “the C...
HLVX Investors Are Invited By The Schall Law Firm To Join Its Investigation Into Alleged Securities Fraud At HilleVax Inc.
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
The Schall Law Firm Invites HLVX Investors To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
HLVX Investors Are Welcomed By The Schall Law Firm To Join Its Inquiry Into Suspected Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
The Schall Law Firm Encourages HLVX Stakeholders To Join Its Probe Into Suspected Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Into Alleged Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
Stakeholders Of HLVX Are Urged To Join The Schall Law Firm's Investigation Of Securities Fraud At HilleVax Inc
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...
HLVX Stakeholders Are Encouraged To Participate In The Securities Fraud Investigation Of HilleVax Inc Led By The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HilleVax, Inc. ("...